Difference in the relative distribution of CD4+ T-cell subsets in B-CLL with mutated and unmutated immunoglobulin (Ig) VH genes: implication for the course of disease.

Tinhofer I, Weiss L, Gassner F, Rubenzer G, Holler C, Greil R. J Immunother. 2009 Apr,32(3):302-9. doi: 10.1097/CJI.0b013e318197b5e4.

VLA-4 and CD38 in chronic lymphocytic leukemia – more than prognostic markers?

Brechtl, G, Denk, U, Pinon-Hofbauer, JD, Greil, R, Hartmann, TN ONKOLOGIE. 2010, 33: 201-202.

The role of the VLA-4 integrin in adhesion and survival of chronic lymphocytic leukemia (CLL) cells

Sahakyan, K, Hofbauer, S, Brachtl, G, Girbl, T, Henschler, R, Greil, R, Hartmann, TN ONKOLOGIE. 2010, 33: 201-201.

Vincristine, idarubicin dexamethasone and thalidomide in scleromyxoedema.

Laimer M, Namberger K, Massone C, Koller J, Emberger M, Pleyer L, Hintner H, Greil R. Acta Derm Venereol. 2009 Nov,89(6):631-5. doi: 10.2340/00015555-0731.

A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells.

Hartmann TN, Grabovsky V, Pasvolsky R, Shulman Z, Buss EC, Spiegel A, Nagler A, Lapidot T, Thelen M, Alon R. J Leukoc Biol. 2008 Oct,84(4):1130-40. doi: 10.1189/jlb.0208088. Epub 2008 Jul 24.

The Dark Side of the Moon – the Side Effects of Therapy in a Dynamic Era of Breast Cancer Management.

Greil R. Breast Care (Basel). 2009,4(3):144-147. Epub 2009 Jun 26.

IMMUNOMODULATORY CAPACITY OF MYELOMA-DERIVED CHEMOKINE CCL27

Johrer, K, Olivier, A, Unger, M, Maizner, E, Neureiter, D, Greil, R ANTICANCER RES. 2008, 28(5C): 3336-3337.

Adjuvant ovarian suppression combined with tamoxifen or anastrozole, alone or in combination with zoledronic acid, in premenopausal women with hormone-responsive, stage I and II breast cancer: First efficacy results from ABCSG-12

Gnant, M, Mlineritsch, B, Schippinger, W, Luschin-Ebengreuth, G, Poestlberger, S, Menzel, C, Jakesz, R, Kubista, E, Marth, C, Greil, R J CLIN ONCOL. 2008, 26(15):

The Austrian Fulvestrant Registry: Results from a prospective observation of fulvestrant in postmenopausal patients

Bartsch, R, Mlineritsch, B, Gnant, M, Niernberger, T, Pluschnig, U, Greil, R, Pober, M, Sevelda, P, Thaler, J, Steger, GG J CLIN ONCOL. 2008, 26(15):

R-CHOP plus thalidomide for previously untreated mantle cell lymphoma

Drach, J, Hopfinger, G, Fridrik, M, Greil, R, Thaler, J, Keil, F, Lang, A, Jaeger, U, Raderer, M ANN ONCOL. 2008, 19: 214-215.